MedTrace Logo

Videocapillaroscopy Assessment During Systemic Agent Therapy in Psoriasis

NCT02162472 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 19

Last updated 2022-01-11

No results posted yet for this study

Summary

The aim of this study is to determine if videocapillaroscopy could be used as an objective and reliable method to assess psoriasis severity and to document improvement during treatment by measuring changes in vascular features.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Joaquin Brieva, MD · Northwestern University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2020-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02162472 on ClinicalTrials.gov